Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026 | The Manila Times
u/guilloherpes — 9 days ago
u/PeacefulProdromes
New Fred Hutch research explains why HSV-2 is so hard to control
u/PeacefulProdromes — 5 days ago